Hudson Bay Capital Management’s Envoy Medical COCH Stock Holding History

Hudson Bay Capital Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-648,999	Closed	-$6.55M	–	883
2022 Q4	$6.55M	Sell	648,999 -51,000	-7%	-$507K	0.07%	274
2022 Q3	$6.88M	Hold	699,999	–	–	0.06%	276
2022 Q2	$6.86M	Hold	699,999	–	–	0.05%	298
2022 Q1	$6.84M	Hold	699,999	–	–	0.09%	251
2021 Q4	$6.83M	Hold	699,999	–	–	0.07%	242
2021 Q3	$6.79M	Hold	699,999	–	–	0.09%	237
2021 Q2	$6.79M	Buy	+699,999	New	+$6.8M	0.08%	245

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Hudson Bay Capital Management's COCH Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 648,999 shares — an estimated $6.55M sold.

Hudson Bay Capital Management first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $6.88M in Q3 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Hudson Bay Capital Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 648,999 Envoy Medical shares in Q1 2023, an estimated $6.55M.
Hudson Bay Capital Management first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Hudson Bay Capital Management's Envoy Medical position peaked at $6.88M in Q3 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.